Teleflex Incorporated (NYSE:TFX) Declares Quarterly Dividend of $0.34

Teleflex Incorporated (NYSE:TFX) declared a quarterly dividend on Thursday, February 27th, RTT News reports. Stockholders of record on Friday, March 7th will be paid a dividend of 0.34 per share by the medical technology company on Monday, March 17th. This represents a $1.36 annualized dividend and a dividend yield of 0.98%.

Teleflex has a dividend payout ratio of 8.2% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $138.99 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex has a 1-year low of $135.95 and a 1-year high of $249.90. The stock has a market capitalization of $6.46 billion, a P/E ratio of 27.63, a P/E/G ratio of 1.73 and a beta of 1.16. The business has a 50-day moving average price of $176.35 and a two-hundred day moving average price of $205.70.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Equities analysts predict that Teleflex will post 13.98 earnings per share for the current year.

Analysts Set New Price Targets

TFX has been the subject of a number of analyst reports. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday. Raymond James cut Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Piper Sandler reiterated a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Friday. Finally, Royal Bank of Canada cut Teleflex from an “outperform” rating to a “sector perform” rating and lowered their target price for the stock from $220.00 to $155.00 in a research note on Friday. Seven research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $207.00.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.